These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12956000)

  • 21. Lack of association with TNF-alpha-308 promoter polymorphism in patients with vitiligo.
    Yazici AC; Erdal ME; Kaya TI; Ikizoglu G; Savasoglu K; Camdeviren H; Tursen U
    Arch Dermatol Res; 2006 Jun; 298(1):46-9. PubMed ID: 16691430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between endothelin-1 gene polymorphisms and susceptibility to vitiligo in a Korean population.
    Kim HJ; Choi CP; Uhm YK; Kim YI; Lee JW; Yoon SH; Chung JH; Lee MH
    Exp Dermatol; 2007 Jul; 16(7):561-6. PubMed ID: 17576235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there a relationship between homocysteine and vitiligo? A pilot study.
    Shaker OG; El-Tahlawi SM
    Br J Dermatol; 2008 Sep; 159(3):720-4. PubMed ID: 18616781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABO blood groups and vitiligo.
    Sehgal VN; Dube B
    J Med Genet; 1968 Dec; 5(4):308-9. PubMed ID: 5713645
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-thyroid peroxidase antibody and vitiligo: a controlled study.
    Daneshpazhooh M; Mostofizadeh G M; Behjati J; Akhyani M; Robati RM
    BMC Dermatol; 2006 Mar; 6():3. PubMed ID: 16526964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABO blood group and secretory status in vitiligo.
    Dutta AK; Mondal SB; Dutta SB
    J Indian Med Assoc; 1969 Aug; 53(4):186-9. PubMed ID: 5361259
    [No Abstract]   [Full Text] [Related]  

  • 27. Increased oxidative DNA damage in mononuclear leukocytes in vitiligo.
    Giovannelli L; Bellandi S; Pitozzi V; Fabbri P; Dolara P; Moretti S
    Mutat Res; 2004 Nov; 556(1-2):101-6. PubMed ID: 15491637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
    Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T
    Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nondeletional ABO*O alleles express weak blood group A phenotypes.
    Seltsam A; Das Gupta C; Wagner FF; Blasczyk R
    Transfusion; 2005 Mar; 45(3):359-65. PubMed ID: 15752153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of ABO blood groups in childhood acute leukemia.
    Alavi S; Ashraf H; Rashidi A; Hosseini N; Abouzari M; Naderifar M
    Pediatr Hematol Oncol; 2006 Dec; 23(8):611-7. PubMed ID: 17065136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [ABO blood group typing in forensic autopsies].
    Nishi K
    Nihon Hoigaku Zasshi; 2005 Oct; 59(2):111-7. PubMed ID: 16296382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABO blood group distribution and major cardiovascular risk factors in patients with acute myocardial infarction.
    Sari I; Ozer O; Davutoglu V; Gorgulu S; Eren M; Aksoy M
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):231-4. PubMed ID: 18388504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of ABO and Rh D blood groups in the population of Poonch District, Azad Jammu and Kashmir.
    Khan MN; Khaliq I; Bakhsh A; Akhtar MS; Amin-ud-Din M
    East Mediterr Health J; 2009; 15(3):717-21. PubMed ID: 19731788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The molecular genetics basis for ABw07 phenotype of ABO subtype].
    Zhu H; Wu Y; Li X; Hong X; Xu X; Zhu F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):678-80. PubMed ID: 19065531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Contribution of the genetic fingerprintings compared to grouping ABO/Rhesus technique in the expertise of filiation].
    Souiden Y; Chaieb K; Romdhani M; Mahdouani K
    Ann Biol Clin (Paris); 2007; 65(6):663-70. PubMed ID: 18039613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of glutathione S-transferase gene polymorphisms (GSTM1 and GSTT1) of vitiligo in Korean population.
    Uhm YK; Yoon SH; Kang IJ; Chung JH; Yim SV; Lee MH
    Life Sci; 2007 Jun; 81(3):223-7. PubMed ID: 17568619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Typing of ABO locus with biological microchip as a new level in solution of problems in forensic-medical biological expertise of material evidences].
    Ivanov PL; Kaganova NL; Zemskova EIu; Bin'ko IA; Mitiaeva ON; Fesenko DO; Nasedkina TV
    Sud Med Ekspert; 2008; 51(2):11-7. PubMed ID: 18450091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased frequency of self-reported parasomnias in patients suffering from vitiligo.
    Mouzas O; Angelopoulos N; Papaliagka M; Tsogas P
    Eur J Dermatol; 2008; 18(2):165-8. PubMed ID: 18424376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABO and rhesus antigens in a cosmopolitan Nigeria population.
    Nwauche CA; Ejele OA
    Niger J Med; 2004; 13(3):263-6. PubMed ID: 15532229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expressional changes in the intracellular melanogenesis pathways and their possible role in the pathogenesis of vitiligo.
    Kingo K; Aunin E; Karelson M; Rätsep R; Silm H; Vasar E; Kõks S
    J Dermatol Sci; 2008 Oct; 52(1):39-46. PubMed ID: 18514490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.